Russia – Healthcare, Regulatory and Reimbursement Landscape
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The Russia pharmaceutical market was valued at $29.0 billion in 2020. The market will grow at a CAGR of more than 4% during the forecast period. The Russia medical devices market was valued at $11.4 billion in 2020 and is expected to grow at a CAGR of less than 1% by 2026. The Russian pharmaceutical market is one of the most significant markets in the Central and Eastern European (CEE) region.
The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Russia. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets.
Russia pharmaceuticals market overview
For more insights on this report, download a free report sample
Russia medical devices market overview
For more insights on this report, download a free report sample
What are the market dynamics in the Russia pharmaceuticals market?
In 2021, Russia was ranked 70th globally on the Legatum Prosperity Index. This rank was driven by the country’s education, economic quality and infrastructure, and market access scores. In 2020, the Russian government approved a package of measures to ensure regular supplies of drugs and avoid shortages in the domestic market. The growth in the Russian healthcare market is attributed to reforms in regulatory guidelines, government initiatives to develop the domestic pharmaceutical market, and the growing elderly population.
Who are the major import and export partners of the Russia pharmaceuticals market?
The major import partners of Russia are Germany, the US, Italy, Switzerland, and Ireland. Germany accounts for the highest percentage in the import business. The major export partners of Russia are Kazakhstan, Ukraine, Belarus, Uzbekistan, and Kyrgyzstan. Among them, Kazakhstan covers the majority of the business.
What are the major sub-segments in the Russia pharmaceuticals market?
The major sub-segments in the Russia pharmaceuticals market are generics, biologics, biosimilars, and over the counter (OTC).
Russia pharmaceuticals market, by sub-segment
For more sub-segment insights, download a free report sample
Who are the major players in the Russia pharmaceuticals market?
The major players in the Russia pharmaceuticals market are GlaxoSmithKline (GSK), Novartis, Pfizer, Sanofi, and Pharmstandard.
GSK
It is a healthcare company that focuses on the development, manufacture, and commercialization of pharmaceuticals, vaccines, and consumer healthcare products. It offers drugs for the treatment of respiratory diseases, cancer, cardiovascular diseases, HIV, infectious diseases, immuno-inflammation, and rare diseases.
Novartis
Novartis is a healthcare company that focuses on the discovery, development, manufacture, and marketing of prescription and generic pharmaceutical products, as well as eye care products. It provides drugs for the treatment of cancer and other diseases.
Pfizer
It is a research-based global biopharmaceutical company that discovers, develops, manufactures, and commercializes drugs for various conditions, consumer healthcare products, generics, and APIs.
Russia pharmaceuticals market, by major players
To know more about major players, download a free report sample
What are the market dynamics in the medical devices market in Russia?
The Russian medical devices market is one of the most attractive and largest markets in the Central and Eastern Europe (CEA) region. The majority of the hospitals here are federally owned and operated, leveraging the Russian government as the primary buyer of medical technology. Although the local medical device manufacturing industry is very small, the Russian government prioritizes domestic products over imported devices while making purchasing decisions. The Russian healthcare system relies on imports. Most of the high technology and innovative products are imported from Europe and the US.
What are the major sub-segments in the medical devices market in Russia?
The major sub-segments in the medical devices market in Russia are hospital supplies, general surgery, orthopedic devices, cardiovascular devices, and anesthesia and respiratory devices. Hospital supplies accounts for the majority of the revenue in the market anesthesia and respiratory devices account for the smallest part of the revenue.
Russia medical devices market, by sub-segment
For more sub-segment insights, download a free report sample
Who are the major players in the medical devices market in Russia?
Some of the major players in the medical devices market in Russia are Roche Diagnostics, Abbott, Zimmer Biomet Holdings Inc, and Medtronic.
Roche Diagnostics
It offers novel diagnostic tests and systems for the early identification, targeted screening, assessment, and monitoring of diseases. The company offers its products and services to hospitals, commercial diagnostic laboratories, healthcare professionals, researchers, and pharmacists.
Abbott
It is a diversified health product company that manufactures and markets drugs, diagnostics, branded generics, vascular products, and nutritional products. The company’s products comprise specialized medicines, medical diagnostic instruments and tests, minimally invasive surgical devices, and products for veterinary care.
Zimmer Biomet Holdings Inc (Zimmer Biomet)
It is a medical devices company focused on musculoskeletal healthcare. The company designs, manufactures, and markets orthopedic reconstructive products, sports medicine, biologics, extremities and trauma products, spine products, craniomaxillofacial and thoracic products, office-based technologies, dental implants, and related surgical products.
Russia medical devices market, by major players
To know more about major players, download a free report sample
Market report scope (pharmaceuticals market)
Market size (Year – 2020) | $29.0 billion |
Growth rate | CAGR of >4% |
Forecast period | 2020-2026 |
Major sub-segments | Generics, Biologics, Biosimilars, and Over the Counter (OTC) |
Major import partners | Germany, the US, Italy, Switzerland, and Ireland |
Major export partners | Kazakhstan, Ukraine, Belarus, Uzbekistan, and Kyrgyzstan |
Major players | GlaxoSmithKline (GSK), Novartis, Pfizer, Sanofi, and Pharmstandard |
Market report scope (medical devices)
Market size (Year – 2020) | $11.4 billion |
Growth rate | CAGR of <1% |
Forecast period | 2020-2026 |
Major sub-segments | Hospital Supplies, General Surgery, Orthopedic Devices, Cardiovascular Devices, and Anesthesia and Respiratory Devices |
Major players | Roche Diagnostics, Abbott, Zimmer Biomet Holdings Inc, and Medtronic |
This report provides:
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
- Profiles and SWOT analyses of the major players in the pharmaceutical market: GSK, Sanofi, Pfizer, Novartis, and Pharmstandard.
- Profiles and SWOT analyses of the major players in the medical device market: Roche, Abbott, Zimmer, and Medtronic.
- An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in the healthcare market, HealthTech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies, and the approval processes for new drugs and medical devices.
- Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure, and healthcare expenditure.
- An overview of the opportunities for and challenges to growth in the Russian healthcare market.
Reasons to Buy
- Develop business strategies by understanding the trends shaping and driving the Russian healthcare market.
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact Russian healthcare market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance.
- Organize sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership.
Table of Contents
Table
Figures
Frequently asked questions
-
What was the Russia pharmaceuticals market size in 2020?
The pharmaceuticals market in Russia was valued at $29.0 billion in 2020.
-
What is the Russia pharmaceuticals market growth rate?
The pharmaceuticals market in Russia will grow at a CAGR of more than 4% from 2020-2026.
-
Who are the major import and export partners of the Russia pharmaceuticals market?
The major import partners of Russia are Germany, the US, Italy, Switzerland, and Ireland. The major export partners of Russia are Kazakhstan, Ukraine, Belarus, Uzbekistan, and Kyrgyzstan.
-
What are the major sub-segments in the Russia pharmaceuticals market?
The major sub-segments in the pharmaceuticals market in Russia are generics, biologics, biosimilars, and over the counter (OTC).
-
Who are the major players in the Russia pharmaceuticals market?
The major players in the Russian pharmaceuticals market are GlaxoSmithKline (GSK), Novartis, Pfizer, Sanofi, and Pharmstandard.
-
What was the Russia medical devices market size in 2020?
The medical devices market in Russia was valued at $11.4 billion in 2020.
-
What is the Russia medical devices market growth rate?
The medical devices market in Russia will grow at a CAGR of less than 1% by 2026.
-
What are the major sub-segments in the Russia medical devices market?
The major sub-segments in the medical devices market in Russia are hospital supplies, general surgery, orthopedic devices, cardiovascular devices, and anesthesia and respiratory devices.
-
Who are the major players in the Russia medical devices market?
The major players in the medical devices market in Russia are Roche Diagnostics, Abbott, Zimmer Biomet Holdings Inc, and Medtronic.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.